,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,5,1,1,,82596,5281691,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H322M Non-Small Cell Lung cell line,Confirmatory,,
1,7,1,1,,82596,5281691,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H460 Non-Small Cell Lung cell line,Confirmatory,,
2,9,1,1,,82596,5281691,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HOP-62 Non-Small Cell Lung cell line,Confirmatory,,
3,13,1,1,,82596,5281691,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line,Confirmatory,,
4,15,1,1,,82596,5281691,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H522 Non-Small Cell Lung cell line,Confirmatory,,
5,19,1,1,,82596,5281691,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the A549/ATCC Non-Small Cell Lung cell line,Confirmatory,,
6,21,1,1,,82596,5281691,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the EKVX Non-Small Cell Lung cell line,Confirmatory,,
7,23,1,1,,82596,5281691,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the LOX IMVI Melanoma cell line,Confirmatory,,
8,25,1,1,,82596,5281691,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the M14 Melanoma cell line,Confirmatory,,
9,29,1,1,,82596,5281691,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line,Confirmatory,,
10,31,1,1,,82596,5281691,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the UACC-62 Melanoma cell line,Confirmatory,,
11,33,1,1,,82596,5281691,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the UACC-257 Melanoma cell line,Confirmatory,,
12,37,1,1,,82596,5281691,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line,Confirmatory,,
13,39,1,1,,82596,5281691,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-28 Melanoma cell line,Confirmatory,,
14,41,1,1,,82596,5281691,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the PC-3 Prostate cell line,Confirmatory,,
15,43,1,1,,82596,5281691,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line,Confirmatory,,
16,45,1,1,,82596,5281691,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-268 Central Nervous System cell line,Confirmatory,,
17,47,1,1,,82596,5281691,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-295 Central Nervous System cell line,Confirmatory,,
18,53,1,1,,82596,5281691,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SNB-19 Central Nervous System cell line,Confirmatory,,
19,59,1,1,,82596,5281691,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the U251 Central Nervous System cell line,Confirmatory,,
20,65,1,1,,82596,5281691,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HT29 Colon cell line,Confirmatory,,
21,67,1,1,,82596,5281691,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the COLO 205 Colon cell line,Confirmatory,,
22,71,1,1,,82596,5281691,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCT-15 Colon cell line,Confirmatory,,
23,77,1,1,,82596,5281691,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCC-2998 Colon cell line,Confirmatory,,
24,79,1,1,,82596,5281691,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCT-116 Colon cell line,Confirmatory,,
25,81,1,1,,82596,5281691,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SW-620 Colon cell line,Confirmatory,,
26,83,1,1,,82596,5281691,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MCF7 Breast cell line,Confirmatory,,
27,85,1,1,,82596,5281691,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MDA-MB-435 Breast cell line,Confirmatory,,
28,87,1,1,,82596,5281691,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line,Confirmatory,,
29,91,1,1,,82596,5281691,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the T-47D Breast cell line,Confirmatory,,
30,93,1,1,,82596,5281691,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI/ADR-RES Breast cell line,Confirmatory,,
31,95,1,1,,82596,5281691,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MDA-MB-231/ATCC Breast cell line,Confirmatory,,
32,99,1,1,,82596,5281691,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-3 Ovarian cell line,Confirmatory,,
33,101,1,1,,82596,5281691,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the IGROV1 Ovarian cell line,Confirmatory,,
34,103,1,1,,82596,5281691,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-OV-3 Ovarian cell line,Confirmatory,,
35,105,1,1,,82596,5281691,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-4 Ovarian cell line,Confirmatory,,
36,107,1,1,,82596,5281691,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-5 Ovarian cell line,Confirmatory,,
37,109,1,1,,82596,5281691,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-8 Ovarian cell line,Confirmatory,,
38,113,1,1,,82596,5281691,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the RPMI-8226 Leukemia cell line,Confirmatory,,
39,115,1,1,,82596,5281691,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SR Leukemia cell line,Confirmatory,,
40,119,1,1,,82596,5281691,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the CCRF-CEM Leukemia cell line,Confirmatory,,
41,121,1,1,,82596,5281691,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the K-562 Leukemia cell line,Confirmatory,,
42,123,1,1,,82596,5281691,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MOLT-4 Leukemia cell line,Confirmatory,,
43,125,1,1,,82596,5281691,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line,Confirmatory,,
44,129,1,1,,82596,5281691,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the A498 Renal cell line,Confirmatory,,
45,131,1,1,,82596,5281691,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the CAKI-1 Renal cell line,Confirmatory,,
46,139,1,1,,82596,5281691,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line,Confirmatory,,
47,141,1,1,,82596,5281691,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the TK-10 Renal cell line,Confirmatory,,
48,143,1,1,,82596,5281691,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line,Confirmatory,,
49,155,1,1,,82596,5281691,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the rad50 strain,Other,,
50,157,1,1,,82596,5281691,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain,Other,,
51,161,1,1,,82596,5281691,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain,Other,,
52,165,1,1,,82596,5281691,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain,Other,,
53,167,1,1,,82596,5281691,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the bub3 strain,Other,,
54,175,1,1,,82596,5281691,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain,Other,,
55,179,1,1,,82596,5281691,Inactive,,,,,NCI AIDS Antiviral Assay,Confirmatory,,
56,608,1,6,,11537641,5281691,Inactive,17149836.0,2280.0,,,NMR Based Screening Assay for FKBP12,Other,,
57,875,1,2,,26749636,5281691,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
58,880,2,1,,26749636,5281691,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
59,880,2,1,,26749636,5281691,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
60,881,2,2,,26749636,5281691,Inconclusive,317373425.0,247.0,12.5893,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
61,884,1,2,,26749636,5281691,Inconclusive,13435386.0,1576.0,39.8107,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
62,885,1,2,,26749636,5281691,Inactive,13435386.0,1576.0,39.8107,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
63,887,1,2,,26749636,5281691,Inactive,1832253.0,246.0,,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
64,889,1,3,,26749636,5281691,Inactive,1730092.0,840.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
65,892,1,2,,26749636,5281691,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
66,893,1,2,,26749636,5281691,Inconclusive,122921310.0,,19.9526,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
67,893,1,2,,26749636,5281691,Inconclusive,122921311.0,,19.9526,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
68,894,2,1,,26749636,5281691,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
69,900,1,3,,26749636,5281691,Inactive,15431328.0,834.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
70,902,1,2,,26749636,5281691,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
71,910,1,2,,26749636,5281691,Inactive,4504349.0,3043.0,,Potency,Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 654 locus,Confirmatory,,
72,923,1,2,,26749636,5281691,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
73,924,1,2,,26749636,5281691,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
74,927,1,3,,26749636,5281691,Inactive,188528692.0,9099.0,,Potency,qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a,Confirmatory,,
75,930,1,2,,26749636,5281691,Inactive,4504349.0,3043.0,,Potency,Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 705 locus,Confirmatory,,
76,940,1,2,,26613342,5281691,Inactive,31881630.0,5732.0,,,Modulators of the EP2 prostaglandin E2 receptor - Primary Screening,Screening,,
77,995,1,2,,26749636,5281691,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
78,1030,2,1,,26749636,5281691,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
79,1033,2,2,,11537641,5281691,Inactive,216546.0,,,,NMR Based Screening Assay for the substrate binding domain of the chaperone DnaK,Screening,,
80,1379,1,2,,26749636,5281691,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
81,1422,1,1,,26613342,5281691,Inactive,31881630.0,5732.0,,,Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen,Screening,,
82,1452,1,1,,26749636,5281691,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
83,1454,1,1,,26749636,5281691,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
84,1457,1,1,,26749636,5281691,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
85,1458,1,1,,26749636,5281691,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
86,1460,1,3,,26749636,5281691,Active,92096784.0,4137.0,5.0119,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
87,1463,1,1,,26749636,5281691,Active,,,19.9526,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
88,1467,1,3,,26749636,5281691,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
89,1468,1,1,,26749636,5281691,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
90,1469,1,1,,26749636,5281691,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
91,1469,1,1,,26753759,5281691,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
92,1476,2,1,,26749636,5281691,Inconclusive,281307097.0,,39.8107,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
93,1477,1,1,,26753759,5281691,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
94,1478,2,1,,26749636,5281691,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
95,1479,1,2,,26749636,5281691,Active,189491771.0,7068.0,50.1187,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
96,1479,1,2,,26753759,5281691,Inconclusive,189491771.0,7068.0,79.4328,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
97,1487,1,1,,26749636,5281691,Inconclusive,27436948.0,4000.0,11.2202,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
98,1490,2,1,,26749636,5281691,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
99,1490,2,1,,26753759,5281691,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
100,1519,1,3,,26749636,5281691,Inactive,,,,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
101,1549,1,2,,11537641,5281691,Inactive,89033149.0,,,,NMR Based Screening Assay for Novel Chemotypes against influenza A virus,Other,,
102,1552,1,3,,11537641,5281691,Inactive,4507793.0,7334.0,,,NMR assay targeting the ubiquitin-proteasome system to modulate protein folding and degradation,Other,,
103,1637,1,2,,11537641,5281691,Inactive,,,,,NMR Based Screening Assay for Influenza A RNA Promoter,Other,,
104,1648,1,2,,11537641,5281691,Inactive,159164579.0,,,,NMR Based Screening Assay For Novel Chemical Probes Targeting The FRB Domain of mTOR,Other,,
105,1766,1,1,,26749636,5281691,Inconclusive,18860839.0,4221.0,31.6228,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
106,1766,1,1,,26749636,5281691,Inconclusive,56550039.0,4297.0,31.6228,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
107,1766,1,1,,26753759,5281691,Inconclusive,18860839.0,4221.0,19.9526,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
108,1766,1,1,,26753759,5281691,Inconclusive,56550039.0,4297.0,19.9526,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
109,1768,1,1,,26749636,5281691,Inconclusive,18860839.0,4221.0,14.1254,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
110,1768,1,1,,26749636,5281691,Inconclusive,56550039.0,4297.0,14.1254,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
111,1768,1,1,,26753759,5281691,Inconclusive,18860839.0,4221.0,28.1838,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
112,1768,1,1,,26753759,5281691,Inconclusive,56550039.0,4297.0,28.1838,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
113,1865,1,1,,26749636,5281691,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
114,1948,1,1,,26749636,5281691,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
115,2101,1,1,,26749636,5281691,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
116,2101,1,1,,26753759,5281691,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
117,2107,1,1,,26749636,5281691,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
118,2107,1,1,,26753759,5281691,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
119,2112,1,1,,26749636,5281691,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
120,2112,1,1,,26753759,5281691,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
121,2147,1,1,,26749636,5281691,Active,221046486.0,,22.3872,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
122,2314,1,2,,26753759,5281691,Inactive,32400299.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
123,2314,1,2,,26753759,5281691,Inactive,32400300.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
124,2315,1,2,,26753759,5281691,Inactive,32400299.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
125,2315,1,2,,26753759,5281691,Inactive,32400300.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
126,2451,1,2,,26749636,5281691,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
127,2451,1,2,,26753759,5281691,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
128,2472,1,2,,26749636,5281691,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
129,2472,1,2,,26753759,5281691,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
130,2517,2,1,,26749636,5281691,Inconclusive,6980812.0,,3.9811,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
131,2517,2,1,,26753759,5281691,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
132,2528,1,2,,26749636,5281691,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
133,2528,1,2,,26753759,5281691,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
134,2546,1,1,,26749636,5281691,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
135,2546,1,1,,26753759,5281691,Inconclusive,188536040.0,19885.0,22.3872,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
136,2549,1,1,,26749636,5281691,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
137,2549,1,1,,26753759,5281691,Inconclusive,282403581.0,,1.9953,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
138,2551,1,1,,26749636,5281691,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
139,2551,1,1,,26753759,5281691,Inconclusive,188536040.0,19885.0,2.2387,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
140,93507,9,2,,103275994,5281691,Unspecified,,,61.6,IC50,IC50 was measured as concentration required to inhibit 50% of HIV-integrase cleavage,Confirmatory,7699704.0,
141,93508,9,2,,103275994,5281691,Active,,,28.7,IC50,IC50 was measured as concentration required to inhibit 50% of HIV-integrase integration,Confirmatory,7699704.0,
142,144650,7,2,,103275994,5281691,Active,,,8.9,GI50,In vitro cytotoxic potency against NCI-60 human tumor cell line,Confirmatory,9632366.0,
143,310882,6,2,,103275994,5281691,Unspecified,,,100.0,EC50,Inhibition of HIV1 replication,Confirmatory,17189684.0,
144,334637,3,5,,103275994,5281691,Unspecified,,,,,Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of 2-aminoanthracene-induced mutation at 600 ug/plate after 72 hrs in presence of Ames S-9 fraction,Other,3069957.0,
145,334638,3,5,,103275994,5281691,Unspecified,,,,,Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of 2-aminoanthracene-induced mutation at 300 ug/plate after 72 hrs in presence of Ames S-9 fraction,Other,3069957.0,
146,334639,3,5,,103275994,5281691,Unspecified,,,,,Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of 2-aminoanthracene-induced mutation at 150 ug/plate after 72 hrs in presence of Ames S-9 fraction,Other,3069957.0,
147,334641,3,5,,103275994,5281691,Unspecified,,,,,Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of acetylaminofluorene-induced mutation at 300 ug/plate after 72 hrs in presence of Ames S-9 fraction,Other,3069957.0,
148,334642,3,5,,103275994,5281691,Unspecified,,,,,Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of acetylaminofluorene-induced mutation at 150 ug/plate after 72 hrs in presence of Ames S-9 fraction,Other,3069957.0,
149,334644,3,5,,103275994,5281691,Unspecified,,,,,Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of benzo[a]pyrene-induced mutation at 300 ug/plate after 72 hrs in presence of Ames S-9 fraction,Other,3069957.0,
150,334645,3,5,,103275994,5281691,Unspecified,,,,,Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of benzo[a]pyrene-induced mutation at 150 ug/plate after 72 hrs in presence of Ames S-9 fraction,Other,3069957.0,
151,334647,3,5,,103275994,5281691,Unspecified,,,,,Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of 2-nitroflorene-induced mutation at 300 ug/plate after 72 hrs,Other,3069957.0,
152,334648,3,5,,103275994,5281691,Unspecified,,,,,Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of 2-nitroflorene-induced mutation at 150 ug/plate after 72 hrs,Other,3069957.0,
153,353590,3,4,,103275994,5281691,Active,,,,,Inhibition of heat-induced HSP70 expression in human Jurkat cells at 50 ug/mL treated for 1 hr before heat induction by Western blot,Other,19296652.0,
154,353591,3,10,,103275994,5281691,Active,19855073.0,3315.0,,,Enhancement of HSP27 Ser78 phosphorylation in human HeLa cells at 50 ug/mL treated for 1 hr,Other,19296652.0,
155,353598,6,2,,103275994,5281691,Active,,,9.7,IC50,Inhibition of CK2 assessed as level of ATP utilized by luciferase-based bioluminescence assay,Confirmatory,19296652.0,
156,353599,6,2,,103275994,5281691,Active,,,8.9,IC50,Inhibition of CAMK2 assessed as level of ATP utilized by luciferase-based bioluminescence assay,Confirmatory,19296652.0,
157,355885,6,2,,103275994,5281691,Unspecified,,,,,Antimicrobial activity against Helicobacter pylori isolates after 36 hrs under aerobic condition by microdilution method,Other,12762812.0,
158,355887,6,2,,103275994,5281691,Inactive,,,,,Antimicrobial activity against Proteus mirabilis isolates after 36 hrs under aerobic condition by microdilution method,Other,12762812.0,
159,355888,3,3,,103275994,5281691,Inactive,,,,,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 after 36 hrs under aerobic condition by microdilution method,Other,12762812.0,
160,379054,6,3,,103275994,5281691,Active,,,22.0,IC50,Inhibition of TNFalpha expression in LPS-stimulated human monocytes treated 30 mins before LPS challenge measured after 14 hrs by ELISA,Confirmatory,10096854.0,
161,379055,4,3,,103275994,5281691,Unspecified,,,,,Cytotoxicity against human monocytes assessed as depletion of cellular LDH activity,Other,10096854.0,
162,400607,4,3,,103275994,5281691,Unspecified,,,,,Inhibition of procoagulant activity in monocyte from human blood assessed as counteraction of IL1-induced tissue factor expression at 10 uM after 18 hrs measured as microunits of tissue factor/10'5 cells,Other,8882428.0,
163,404067,3,5,,103275994,5281691,Inactive,,,,,In vivo antitumor activity against mouse S180 cells,Other,469554.0,
164,404069,3,5,,103275994,5281691,Inactive,,,,,In vivo antitumor activity against mouse L1210 cells,Other,469554.0,
165,404070,3,4,,103275994,5281691,Inactive,,,,,In vivo antitumor activity against mouse CA-755 cells,Other,469554.0,
166,404692,9,5,,103275994,5281691,Unspecified,1351933.0,276.0,,IC50,Inhibition of human salivary alpha-amylase,Confirmatory,18507367.0,
167,404692,9,5,,103275994,5281691,Unspecified,1351933.0,277.0,,IC50,Inhibition of human salivary alpha-amylase,Confirmatory,18507367.0,
168,404692,9,5,,103275994,5281691,Unspecified,1351933.0,278.0,,IC50,Inhibition of human salivary alpha-amylase,Confirmatory,18507367.0,
169,423636,6,2,,103275994,5281691,Active,,,7.8,IC50,Cytotoxicity against human HeLa cells by MTT assay,Confirmatory,19278239.0,
170,426927,3,4,,103275994,5281691,Unspecified,,,,,Cytotoxicity against african green monkey Vero cells after 3 days by MTT assay,Other,19422205.0,
171,426928,4,4,,103275994,5281691,Inactive,,,,,Antiviral activity against HSV1 infected in african green monkey Vero cells assessed as total inhibitory concentration after 3 days by plaque reduction assay,Other,19422205.0,
172,456317,3,3,,103275994,5281691,Unspecified,,,,,Antioxidant activity assessed as trolox equivalent by TEAC assay,Other,19944611.0,
173,485281,1,1,,26749636,5281691,Inactive,254220970.0,,,Potency,qHTS Assay for Identification of Novel General Anesthetics,Confirmatory,,
174,485281,1,1,,26753759,5281691,Inactive,254220970.0,,,Potency,qHTS Assay for Identification of Novel General Anesthetics,Confirmatory,,
175,485290,1,1,,26749636,5281691,Inactive,20150581.0,,31.6228,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
176,485290,1,1,,26753759,5281691,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
177,504327,1,1,,26749636,5281691,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
178,504327,1,1,,26753759,5281691,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
179,504847,1,1,,26749636,5281691,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
180,504847,1,1,,26753759,5281691,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
181,504865,1,1,,26749636,5281691,Inactive,118600387.0,7398.0,,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
182,588579,1,1,,26749636,5281691,Active,7705344.0,51426.0,3.9811,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
183,588579,1,1,,26753759,5281691,Active,7705344.0,51426.0,0.9466,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
184,596669,1,4,,103275994,5281691,Unspecified,,,,,Induction of adipogenesis in mouse 3T3L1 cells assessed as increase in triglyceride level at 0.3 uM on day 8 relative to control,Other,21493073.0,
185,596670,1,4,,103275994,5281691,Unspecified,,,,,Induction of adipogenesis in mouse 3T3L1 cells assessed as increase in triglyceride level at 1 uM on day 8 relative to control,Other,21493073.0,
186,596671,1,4,,103275994,5281691,Unspecified,,,,,Induction of adipogenesis in mouse 3T3L1 cells assessed as increase in triglyceride level at 3 uM on day 8 relative to control,Other,21493073.0,
187,596672,1,4,,103275994,5281691,Unspecified,,,,,Induction of adipogenesis in mouse 3T3L1 cells assessed as increase in triglyceride level at 10 uM on day 8 relative to control,Other,21493073.0,
188,596673,1,4,,103275994,5281691,Unspecified,,,,,Induction of adipogenesis in mouse 3T3L1 cells assessed as increase in triglyceride level at 30 uM on day 8 relative to control,Other,21493073.0,
189,602332,1,1,,26749636,5281691,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
190,602332,1,1,,26753759,5281691,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
191,603831,1,4,,103275994,5281691,Active,,,,,Increase in c-Fos protein expression in human MDA-MB-231 cells at 20 uM within 30 mins by Western blot analysis,Other,21652208.0,
192,603832,1,4,,103275994,5281691,Active,,,,,Increase in Egr-1 protein expression in human MDA-MB-231 cells at 20 uM within 30 mins by Western blot analysis,Other,21652208.0,
193,603833,1,4,,103275994,5281691,Inactive,,,,,Effect on p38 kinase protein level in human MDA-MB-231 cells at 20 uM up to 120 mins by Western blot analysis,Other,21652208.0,
194,603834,1,4,,103275994,5281691,Inactive,,,,,Effect on JNK2 protein level in human MDA-MB-231 cells at 20 uM up to 120 mins by Western blot analysis,Other,21652208.0,
195,603835,1,4,,103275994,5281691,Inactive,,,,,Effect on JNK1 protein level in human MDA-MB-231 cells at 20 uM up to 120 mins by Western blot analysis,Other,21652208.0,
196,603836,1,4,,103275994,5281691,Inactive,,,,,Effect on ERK2 protein level in human MDA-MB-231 cells at 20 uM up to 120 mins by Western blot analysis,Other,21652208.0,
197,603837,1,4,,103275994,5281691,Inactive,,,,,Effect on ERK1 protein level in human MDA-MB-231 cells at 20 uM up to 120 mins by Western blot analysis,Other,21652208.0,
198,603838,1,5,,103275994,5281691,Unspecified,2499600.0,1432.0,,,Increase in p38 kinase phosphorylation in human MDA-MB-231 cells at 20 uM by Western blot analysis,Other,21652208.0,
199,603838,1,5,,103275994,5281691,Unspecified,2851522.0,6300.0,,,Increase in p38 kinase phosphorylation in human MDA-MB-231 cells at 20 uM by Western blot analysis,Other,21652208.0,
200,603838,1,5,,103275994,5281691,Unspecified,6685642.0,5603.0,,,Increase in p38 kinase phosphorylation in human MDA-MB-231 cells at 20 uM by Western blot analysis,Other,21652208.0,
201,603838,1,5,,103275994,5281691,Unspecified,134047835.0,5600.0,,,Increase in p38 kinase phosphorylation in human MDA-MB-231 cells at 20 uM by Western blot analysis,Other,21652208.0,
202,603839,1,9,,103275994,5281691,Unspecified,85700366.0,5601.0,,,Increase in JNK2 phosphorylation in human MDA-MB-231 cells at 20 uM by Western blot analysis,Other,21652208.0,
203,603840,1,9,,103275994,5281691,Unspecified,119554.0,5594.0,,,Increase in ERK2 phosphorylation in human MDA-MB-231 cells at 20 uM by Western blot analysis,Other,21652208.0,
204,603841,1,9,,103275994,5281691,Unspecified,2507195.0,5599.0,,,Increase in JNK1 phosphorylation in human MDA-MB-231 cells at 20 uM by Western blot analysis,Other,21652208.0,
205,603842,1,10,,103275994,5281691,Unspecified,232066.0,5595.0,,,Increase in ERK1 phosphorylation in human MDA-MB-231 cells at 20 uM by Western blot analysis,Other,21652208.0,
206,603843,1,4,,103275994,5281691,Active,,,,,Induction of apoptosis in human MDA-MB-231 cells assessed as cleaved caspase-7 accumulation at 20 uM after 12 hrs by Western blot analysis,Other,21652208.0,
207,603844,1,3,,103275994,5281691,Unspecified,,,,,Stability of the compound in DMEM media assessed as compound degradation at 25 ppm after 3 hrs by HPLC,Other,21652208.0,
208,624263,1,1,,26749636,5281691,Inactive,3063388.0,5071.0,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
209,624263,1,1,,26749636,5281691,Inactive,37183032.0,,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
210,639825,5,5,,103275994,5281691,Active,113596.0,231.0,2.7,IC50,Inhibition of human recombinant aldose reductase using D-glyceraldehyde as substrate preincubated for 10 mins before substrate addition measured for every 10 secs for 50 mins by spectrophotometry,Confirmatory,22261024.0,
211,654747,1,8,,103275994,5281691,Inactive,137757.0,1489078.0,,,Inhibition of GST-tagged Human papillomavirus 16 protein E6 interaction with His-tagged human caspase 8 expressed in Escherichia coli at 20 nM to 20 uM after 1 hr incubation followed by overnight incubation by Alpha screening technique,Other,22300659.0,
212,666768,1,7,,103275994,5281691,Unspecified,75057499.0,,,,Inhibition of thrombin in New Zealand rabbit plasma assessed as thrombin time at 100 uM after 3 mins by coagulometry,Other,22647223.0,
213,666769,1,7,,103275994,5281691,Unspecified,75057499.0,,,,Inhibition of thrombin in New Zealand rabbit plasma assessed as prothrombin time at 100 uM by coagulometry,Other,22647223.0,
214,666770,1,7,,103275994,5281691,Unspecified,75057499.0,,,,Inhibition of thrombin in New Zealand rabbit plasma assessed as activated partial thromboplastin time at 100 uM after 3 mins by coagulometry,Other,22647223.0,
215,666771,1,7,,103275994,5281691,Unspecified,75057499.0,,,,Inhibition of thrombin in New Zealand rabbit plasma assessed as fibrinogen level at 100 uM by coagulometry,Other,22647223.0,
216,686978,1,1,,26749636,5281691,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
217,686979,1,1,,26749636,5281691,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
218,697852,1,7,,103275994,5281691,Unspecified,14916521.0,,,,Inhibition of electric eel AChE at 2 mg/ml by Ellman's method,Other,23062825.0,
219,697853,1,7,,103275994,5281691,Unspecified,21362409.0,100033901.0,,,Inhibition of horse BChE at 2 mg/ml by Ellman's method,Other,23062825.0,
220,720532,1,1,,26749636,5281691,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
221,720532,1,1,,26753759,5281691,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
222,720533,1,1,,26749636,5281691,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
223,720533,1,1,,26753759,5281691,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
224,720579,2,1,,26749636,5281691,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
225,720580,1,1,,26749636,5281691,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
226,977599,1,1,,103275994,5281691,Unspecified,,,,,Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Other,23571415.0,
227,977602,1,2,,103275994,5281691,Unspecified,,,,,Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Other,23571415.0,
228,1066473,1,2,,103275994,5281691,Active,2499600.0,1432.0,,,Binding affinity to human p38 MAPK expressed in Escherichia coli by circular dichroism method,Other,24397781.0,
229,1066473,1,2,,103275994,5281691,Active,2851522.0,6300.0,,,Binding affinity to human p38 MAPK expressed in Escherichia coli by circular dichroism method,Other,24397781.0,
230,1066473,1,2,,103275994,5281691,Active,6685642.0,5603.0,,,Binding affinity to human p38 MAPK expressed in Escherichia coli by circular dichroism method,Other,24397781.0,
231,1066473,1,2,,103275994,5281691,Active,134047835.0,5600.0,,,Binding affinity to human p38 MAPK expressed in Escherichia coli by circular dichroism method,Other,24397781.0,
232,1066474,1,4,,103275994,5281691,Active,2507195.0,5599.0,,,Binding affinity to human C-terminal His6-tagged JNK1alpha1 (1 to 364) expressed in Escherichia coli by circular dichroism method,Other,24397781.0,
233,1066475,2,2,,103275994,5281691,Unspecified,2499600.0,1432.0,,,Binding affinity to human p38 MAPK expressed in Escherichia coli by spectrofluorometry,Other,24397781.0,
234,1066475,2,2,,103275994,5281691,Unspecified,2851522.0,6300.0,,,Binding affinity to human p38 MAPK expressed in Escherichia coli by spectrofluorometry,Other,24397781.0,
235,1066475,2,2,,103275994,5281691,Unspecified,6685642.0,5603.0,,,Binding affinity to human p38 MAPK expressed in Escherichia coli by spectrofluorometry,Other,24397781.0,
236,1066475,2,2,,103275994,5281691,Unspecified,134047835.0,5600.0,,,Binding affinity to human p38 MAPK expressed in Escherichia coli by spectrofluorometry,Other,24397781.0,
237,1066476,2,3,,103275994,5281691,Unspecified,2507195.0,5599.0,,,Binding affinity to human C-terminal His6-tagged JNK1alpha1 (1 to 364) expressed in Escherichia coli by spectrofluorometry,Other,24397781.0,
238,1066477,1,4,,103275994,5281691,Inactive,115957.0,12475.0,,,Inhibition of CD14 in mouse RAW264.7 cells at 20 uM by Western blotting analysis,Other,24397781.0,
239,1066478,1,4,,103275994,5281691,Unspecified,22653814.0,26419.0,,,Inhibition of IFNgamma-induced JNK phosphorylation in mouse RAW264.7 cells at 20 uM by Western blotting analysis relative to untreated control,Other,24397781.0,
240,1066479,1,4,,103275994,5281691,Unspecified,52001483.0,26417.0,,,Inhibition of IFNgamma-induced ERK phosphorylation in mouse RAW264.7 cells at 20 uM by Western blotting analysis relative to untreated control,Other,24397781.0,
241,1066480,1,1,,103275994,5281691,Unspecified,,,,,Inhibition of IFNgamma-induced p38 MAPK phosphorylation in mouse RAW264.7 cells at 20 uM by Western blotting analysis relative to untreated control,Other,24397781.0,
242,1066481,1,2,,103275994,5281691,Unspecified,,,,,Antiinflammatory activity against mouse RAW264.7 cells assessed as reduction of IFNgamma-induced NO production at 20 uM after 24 hrs,Other,24397781.0,
243,1066482,1,2,,103275994,5281691,Unspecified,,,,,Antiinflammatory activity against mouse RAW264.7 cells assessed as reduction of IFNgamma-induced NO production at 10 uM after 24 hrs,Other,24397781.0,
244,1066483,1,2,,103275994,5281691,Unspecified,,,,,Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced COX2 protein expression at 20 uM by Western blotting analysis,Other,24397781.0,
245,1066484,1,4,,103275994,5281691,Unspecified,52001483.0,26417.0,,,Inhibition of LPS-induced ERK phosphorylation in mouse RAW264.7 cells at 20 uM by Western blotting analysis,Other,24397781.0,
246,1066485,1,1,,103275994,5281691,Unspecified,,,,,Inhibition of LPS-induced p38 MAPK phosphorylation in mouse RAW264.7 cells at 20 uM by Western blotting analysis,Other,24397781.0,
247,1066486,1,4,,103275994,5281691,Unspecified,22653814.0,26419.0,,,Inhibition of LPS-induced JNK phosphorylation in mouse RAW264.7 cells at 20 uM by Western blotting analysis,Other,24397781.0,
248,1066487,1,2,,103275994,5281691,Unspecified,,,,,Antiinflammatory activity against mouse RAW264.7 cells assessed as reduction of LPS-induced mMIP-1 mRNA expression at 25 uM after 3 hrs by RT-PCR analysis relative to untreated control,Other,24397781.0,
249,1066488,1,2,,103275994,5281691,Active,,,,,Antiinflammatory activity against mouse RAW264.7 cells assessed as reduction of LPS-induced mTNFalpha mRNA expression at 25 uM after 3 hrs by RT-PCR analysis relative to untreated control,Other,24397781.0,
250,1066489,1,2,,103275994,5281691,Active,,,,,Antiinflammatory activity against mouse RAW264.7 cells assessed as reduction of LPS-induced mMIP-2 mRNA expression at 25 uM after 3 hrs by RT-PCR analysis relative to untreated control,Other,24397781.0,
251,1066490,1,2,,103275994,5281691,Unspecified,,,,,Antiinflammatory activity against mouse RAW264.7 cells assessed as reduction of LPS-induced mMIP-2 level at 20 uM after 24 hrs by ELISA relative to untreated control,Other,24397781.0,
252,1066491,1,2,,103275994,5281691,Unspecified,,,,,Antiinflammatory activity against mouse RAW264.7 cells assessed as reduction of LPS-induced mMIP-2 level at 10 uM after 24 hrs by ELISA relative to untreated control,Other,24397781.0,
253,1066492,1,2,,103275994,5281691,Unspecified,,,,,Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced TNFalpha production at 20 uM after 24 hrs by ELISA,Other,24397781.0,
254,1066493,1,2,,103275994,5281691,Unspecified,,,,,Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced TNFalpha production at 10 uM after 24 hrs by ELISA,Other,24397781.0,
255,1066494,1,2,,103275994,5281691,Unspecified,,,,,Antiinflammatory activity against mouse RAW264.7 cells assessed as reduction of LPS-induced NO production at 20 uM after 24 hrs,Other,24397781.0,
256,1066495,1,2,,103275994,5281691,Unspecified,,,,,Antiinflammatory activity against mouse RAW264.7 cells assessed as reduction of LPS-induced NO production at 10 uM after 24 hrs,Other,24397781.0,
257,1066496,1,2,,103275994,5281691,Unspecified,,,,,Cytotoxicity against human HaCaT cells at 100 uM after 24 hrs by MTT assay relative to untreated control,Other,24397781.0,
258,1066497,1,2,,103275994,5281691,Unspecified,,,,,Cytotoxicity against mouse RAW264.7 cells assessed as cell survival at 100 uM after 24 hrs by MTT assay relative to untreated control,Other,24397781.0,
259,1066498,1,2,,103275994,5281691,Unspecified,,,,,Cytotoxicity against mouse RAW264.7 cells up to 12.5 uM after 24 hrs by MTT assay relative to untreated control,Other,24397781.0,
260,1084380,1,4,,103275994,5281691,Unspecified,75651200.0,,,,Inhibition of Avian myeloblastosis virus reverse transcriptase,Other,,
261,1098728,1,2,,103275994,5281691,Unspecified,,,,,Antifeedant activity against fifth instar larvae of Spodoptera littoralis fed on compound-treated lettuce leaf at 10 ug/cm'2 by leaf-disk method,Other,,
262,1098729,1,2,,103275994,5281691,Inconclusive,,,,,Toxicity against Artemia salina (brine shrimp) after 24 hr,Other,,
263,1153995,1,1,,103275994,5281691,Unspecified,,,,,Intracellular melanogenesis-stimulating activity in mouse B16F0 cells at 25 uM after 72 hrs by spectrophotometry relative to control,Other,24853321.0,
264,1153996,1,1,,103275994,5281691,Unspecified,,,,,Intracellular melanogenesis-stimulating activity in mouse B16F0 cells at 12.5 uM after 72 hrs by spectrophotometry relative to control,Other,24853321.0,
265,1153997,1,1,,103275994,5281691,Unspecified,,,,,Intracellular melanogenesis-stimulating activity in mouse B16F0 cells at 6.25 uM after 72 hrs by spectrophotometry relative to control,Other,24853321.0,
266,1153999,1,1,,103275994,5281691,Unspecified,,,,,Extracellular melanogenesis-stimulating activity in mouse B16F0 cells at 25 uM after 72 hrs by spectrophotometry relative to control,Other,24853321.0,
267,1154000,1,1,,103275994,5281691,Unspecified,,,,,Extracellular melanogenesis-stimulating activity in mouse B16F0 cells at 12.5 uM after 72 hrs by spectrophotometry relative to control,Other,24853321.0,
268,1154001,1,1,,103275994,5281691,Unspecified,,,,,Extracellular melanogenesis-stimulating activity in mouse B16F0 cells at 6.25 uM after 72 hrs by spectrophotometry relative to control,Other,24853321.0,
269,1154003,1,1,,103275994,5281691,Unspecified,,,,,Cytotoxicity against mouse B16F0 cells assessed as cell viability at 25 uM after 72 hrs by MTT assay,Other,24853321.0,
270,1154004,1,1,,103275994,5281691,Unspecified,,,,,Cytotoxicity against mouse B16F0 cells assessed as cell viability at 12.5 uM after 72 hrs by MTT assay,Other,24853321.0,
271,1154005,1,1,,103275994,5281691,Unspecified,,,,,Cytotoxicity against mouse B16F0 cells assessed as cell viability at 6.25 uM after 72 hrs by MTT assay,Other,24853321.0,
272,1159524,1,1,,26749636,5281691,Inactive,,,,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
273,1159550,3,1,,252401396,5281691,Inactive,12653201.0,5226.0,,,Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening,Screening,26479318.0,
274,1159580,2,1,,268736610,5281691,Active,,,,,"The chemical genetic matrix (CGM) dataset as reported in Wildenhain et al. (2015) Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning. Cell Systems Volume 1, Issue 6, p383-395",Summary,,
275,1159607,2,1,,312996124,5281691,Inactive,,,,,Screen for inhibitors of RMI FANCM (MM2) intereaction,Other,26962873.0,
276,1259310,1,1,,333495381,5281691,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
277,1259389,1,1,,124636406,5281691,Inactive,,,,,HIV1_TAR : FRET assay measuring displacement of FAM and TAMRA-labeled Tat peptide from HIV-1 TAR RNA.,Screening,,
278,1259407,1,1,,363901742,5281691,Inactive,,,,,CCRIS mutagenicity studies,Other,,
279,1259408,1,1,,363895126,5281691,Unspecified,,,,,GENE-TOX mutagenicity studies,Other,,
280,1259423,1,2,,354976815,5281691,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
